Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02511782 · ClinicalTrials.gov registry record · NA
Transdermal Patch to Monitor Inflammatory Biomarkers of GVHD
A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT02511782 is a NA study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 63 participants.
The verdict
NCT02511782, a NA study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
The aim of this study is to measure local inflammatory responses in patients undergoing an allogeneic stem cell transplant and attempt to define any set of biomarkers that are significantly altered in acute or chronic skin graft versus host disease.
Interventions
- DEVICE D-SQUAME Skin Sampling Discs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2012-02 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02511782
The ClinicalTrials.gov registry entry for NCT02511782 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which D-SQUAME Skin Sampling Discs is the first listed.
NCT02511782 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02511782 about?
NCT02511782 is a clinical study titled "Transdermal Patch to Monitor Inflammatory Biomarkers of GVHD". The aim of this study is to measure local inflammatory responses in patients undergoing an allogeneic stem cell transplant and attempt to define any set of biomarkers that are significantly altered in acute or chronic skin graft versus host disease.
What is the current status of trial NCT02511782?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2012-02. Estimated completion is 2014-10.
What interventions are being tested in trial NCT02511782?
The interventions under investigation include: D-SQUAME Skin Sampling Discs (DEVICE).
Who is sponsoring clinical trial NCT02511782?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.